Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 19, 2021
January 20, 2021
20ac34c3-75bd-45e5-8338-ca633985c05c
Related Documents
Recommendations for Investigational and Licensed COVID-19 Convalescent Plasma: Guidance for Industry
Guidance DocumentJuly 19, 2024Center for Biologics Evaluation and Research
Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry
Guidance DocumentOctober 19, 2023Center for Biologics Evaluation and Research
Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Guidance for Industry
Guidance DocumentDecember 7, 2022Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.